N-myristoyltransferase (NMT) is an essential eukaryotic enzyme which catalyzes the transfer of the myristoyl group to the terminal glycine residue of a number of proteins including those involved in signal transduction and apoptotic pathways. In higher eukaryotes, two isoforms of NMT have been identified (NMT1 and NMT2) which share about 76% amino acid sequence identity in humans. Protein-protein interactions of NMTs reveal that m-calpain interacts with NMT1 whereas caspase-3 interacts with NMT2. These findings reveal differential interactions of both isoforms of NMT with various signaling molecules. This minireview provides an overview of the regulation of N-myristoyltransferase by calpain and caspase systems.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
VP0 Myristoylation Is Essential for Senecavirus A Replication.
Pathogens
July 2024
State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Article Synopsis
- Many picornaviruses, including Senecavirus A (SVA), depend on myristoylation of their capsid proteins for effective viral replication, which is facilitated by the enzyme N-myristoyltransferase (NMT).
- Research showed that inhibitors of NMT can effectively block SVA replication, and that knocking out NMT1 in specific cells led to reduced viral replication, while increasing its expression supported replication.
- The study established that myristoylation of SVA’s VP0 protein is crucial for its function and distribution within cells, with specific residues in the protein's structure playing key roles in its ability to replicate.
A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas.
Invest New Drugs
August 2024
Pacylex Pharmaceuticals Inc., Edmonton, AB, Canada.
Myristoylation, the N-terminal addition of the fatty acid myristate to proteins, regulates membrane-bound signal transduction pathways important in cancer cell biology. This modification is catalyzed by two N-myristoyltransferases, NMT1 and NMT2. Zelenirstat is a first-in-class potent oral small molecule inhibitor of both NMT1 and NMT2 proteins.
View Article and Find Full Text PDFMultiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition.
J Transl Med
May 2024
Pacylex Pharmaceuticals Inc., Edmonton, AB, Canada.
Background: In humans, two ubiquitously expressed N-myristoyltransferases, NMT1 and NMT2, catalyze myristate transfer to proteins to facilitate membrane targeting and signaling. We investigated the expression of NMTs in numerous cancers and found that NMT2 levels are dysregulated by epigenetic suppression, particularly so in hematologic malignancies. This suggests that pharmacological inhibition of the remaining NMT1 could allow for the selective killing of these cells, sparing normal cells with both NMTs.
View Article and Find Full Text PDFRegulation of FSP1 myristoylation by NADPH: A novel mechanism for ferroptosis inhibition.
Redox Biol
July 2024
Department of Pharmacology College of Pharmaceutical Sciences, Suzhou Key Laboratory of Aging and Nervous Diseases, and Jiangsu Key Laboratory of Neuropsychiatric Diseases, Soochow University, Suzhou, Jiangsu, China. Electronic address:
Article Synopsis
- Excitotoxicity is a key factor in neurodegenerative diseases, and its connection to ferroptosis (a form of cell death) is not well understood.
- This study finds that NADPH not only acts as a reductant but also interacts with N-myristoyltransferase 2 (NMT2), leading to increased levels of a protein (FSP1) that helps resist ferroptosis.
- The research highlights that the interaction between NADPH, NMT2, and FSP1 is crucial for understanding how neurons can withstand ferroptosis, potentially offering new avenues for treating related diseases.
Targeting N-Myristoylation Through NMT2 Prevents Cardiac Hypertrophy and Heart Failure.
JACC Basic Transl Sci
October 2023
Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Protein diversity can increase via N-myristoylation, adding myristic acid to an N-terminal glycine residue. In a murine model of pressure overload, knockdown of cardiac N-myristoyltransferase 2 (NMT2) by adeno-associated virus 9 exacerbated cardiac dysfunction, remodeling, and failure. Click chemistry-based quantitative chemical proteomics identified substrate proteins of N-myristoylation in cardiac myocytes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!